ORITAVANCIN DIPHOSPHATE vs ORLISTAT: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ORITAVANCIN DIPHOSPHATE vs ORLISTAT: Safety Overview
| Metric | ORITAVANCIN DIPHOSPHATE | ORLISTAT |
|---|---|---|
| Total FAERS Reports | 276 | 6,498 |
| Deaths Reported | 4 | 31 |
| Death Rate | 1.4% | 0.5% |
| Hospitalizations | 27 | 329 |
| Average Patient Age | 58.5 yrs | 49.0 yrs |
| % Female Patients | 39.2% | 83.9% |
| FDA Approval Date | Aug 6, 2014 | Apr 23, 1999 |
| Manufacturer | Melinta Therapeutics, LLC | H2-Pharma LLC |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |